InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（7 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
7
T+90 胜率
33%
T+90 平均收益
-1.9%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Brynjelsen Sean, 首席执行官. Insider active across 1 company, notably Eton Pharmaceuticals, Inc.. Cumulatively, 14 reports have been published. Breakdown: 3 buys · 7 sells. Total volume traded: €9.5m. History available since 3 June 2021. The latest transaction was filed on 19 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Brynjelsen Sean
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
8,978 股@ US$62.65Common StockSEC:0001437749-26-028651:0
47,307 股@ US$60.17Common StockSEC:0001437749-26-028651:1
36,373 股@ US$61.11Common StockSEC:0001437749-26-028651:2
7,342 股@ US$62.12Common StockSEC:0001437749-26-028651:3
200,000 股@ US$1.370.016% mcap5.1% 占其流量Common StockSEC:0001437749-26-023570:1
27,500 股Common StockSEC:0001437749-26-023570:0
119,852 股@ US$31.880.21% mcap87.4% 占其流量Common StockSEC:0001437749-26-018879:0
148 股@ US$32.670.0003% mcap0.1% 占其流量Common StockSEC:0001437749-26-018879:1
5,015 股@ US$15.390.0042% mcap14.7% 占其流量Common StockSEC:0001437749-26-001290:0
6,732 股@ US$16.830.0062% mcap21.6% 占其流量Common StockSEC:0001437749-25-037741:0
60,945 股@ US$17.3820.8% 占其流量Common StockSEC:0001437749-25-019583:0
10,000 股@ US$2.10420.6% 占其流量Common StockSEC:0001493152-22-026629:0
标准退出：2022年12月21日 (T+90)
10,000 股@ US$4.320.8% 占其流量Common StockSEC:0001493152-21-020807:0
标准退出：2021年11月18日 (T+90)
5,000 股@ US$5.960.5% 占其流量Common StockSEC:0001493152-21-013513:0
标准退出：2021年9月1日 (T+90)
14 条申报中的 14 条
About Brynjelsen Sean
BRYNJELSEN SEAN is Directeur Général and also holds the role of President & CEO at Eton Pharmaceuticals, Inc. The 10 filings recorded span from 2021-06-03 to 2026-07-14 in the recent filings tracked, with EUR 82,939 of buys and EUR 4,224,354 of sells, and the most frequent transaction nature is sale.
